Page 38 - ITPS-7-3
P. 38
INNOSC Theranostics and
Pharmacological Sciences Therapeutic value of terpenes
cancer cells through the activation of p53. PLoS One. doi: 10.1111/bcpt.12010
2012;7(12):e53178.
348. Perry G, Roder H, Nunomura A, et al. Activation of
doi: 10.1371/journal.pone.0053178 neuronal extracellular receptor kinase (ERK) in Alzheimer
disease links oxidative stress to abnormal phosphorylation.
338. Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-cancer
potential of cannabinoids, terpenes, and flavonoids present Neuroreport. 1999;10(11):2411-2415.
in cannabis. Cancers (Basel). 2020;12(7):1985. doi: 10.1097/00001756-199908020-00035
doi: 10.3390/cancers12071985 349. Chen MJ, Ramesha S, Weinstock LD, et al. Extracellular
signal‐regulated kinase regulates microglial immune
339. Ding C, Wu Y, Chen X, et al. Global, regional, and national
burden and attributable risk factors of neurological responses in Alzheimer’s disease. J Neurosci Res.
disorders: The Global Burden of Disease study 1990-2019. 2021;99(6):1704-1721.
Front Public Health. 2022;10:952161. doi: 10.1002/jnr.24829
doi: 10.3389/fpubh.2022.952161 350. Cutillas A-B, Carrasco A, Martinez-Gutierrez R, Tomas V,
Tudela J. Rosmarinus officinalis L. Essential oils from Spain:
340. Bloomberg. Insights on Global Neurodegenerative Disease Composition, antioxidant capacity, lipoxygenase and
Market Size and Share to Reach USD 47911.88 Million by
2028, Exhibit a CAGR of 3.1%. Available from: https:// acetylcholinesterase inhibitory capacities, and antimicrobial
www.bloomberg.com/press-releases/2022-07-27/ activities. Plant Biosyst Int J Dealing Aspects Plant Biol.
insights-on-global-neurodegenerative-disease-market- 2018;152(6):1282-1292.
size-share-to-reach-usd-47911-88-million-by-2028- doi: 10.1080/11263504.2018.1445129
exhibit-a-cagr-of-3-1 [Last accessed on 2023 Feb 07].
351. Armstrong D, Stratton RD. Oxidative Stress and Antioxidant
341. Auti ST, Kulkarni YA. A systematic review on the role of Protection: The Science of free Radical Biology and Disease.
natural products in modulating the pathways in Alzheimer’s Hoboken: John Wiley and Sons; 2016.
disease. Int J Vitam Nutr Res. 2017;87(1-2):99-116. 352. Federation ID. Diabetes Around the World in 2021.
doi: 10.1024/0300-9831/a000405 Available from: https://diabetesatlas.org [Last accessed on
2023 Feb 07].
342. World Health Organization. Dementia. Available from:
https://www.who.int/news-room/fact-sheets/detail/ 353. World Health Organization. Diabetes. Available from:
dementia [Last accessed on 2023 Feb 07]. https://www.who.int/health-topics/diabetes#tab=tab_1
[Last accessed on 2023 Feb 07].
343. Gooch CL, Pracht E, Borenstein AR. The burden of
neurological disease in the United States: A summary 354. Saeedi P, Petersohn I, Salpea P, et al. Global and regional
report and call to action. Ann Neurol. 2017;81(4):479-484. diabetes prevalence estimates for 2019 and projections for
2030 and 2045: Results from the International Diabetes
doi: 10.1002/ana.24897
Federation Diabetes Atlas. Diabetes Res Clin Pract.
344. AlFadly ED, Elzahhar PA, Tramarin A, et al. Tackling 2019;157:107843.
neuroinflammation and cholinergic deficit in Alzheimer’s doi: 10.1016/j.diabres.2019.107843
disease: Multi-target inhibitors of cholinesterases,
cyclooxygenase-2 and 15-lipoxygenase. Eur J Med Chem. 355. Centers for Disease Control and Prevention. Diabetes and
2019;167:161-186. Your Heart. Available from: https://www.cdc.gov/diabetes/
library/features/diabetes-and-heart.html [Last accessed on
doi: 10.1016/j.ejmech.2019.02.012
2023 Feb 07].
345. Nazaruk J, Borzym-Kluczyk M. The role of triterpenes in 356. Cleveland Clinic. Diabetes. Available from: https://
the management of diabetes mellitus and its complications. my.clevelandclinic.org/health/diseases/7104-diabetes [Last
Phytochem Rev. 2015;14:675-690.
accessed on 2023 Feb 07].
doi: 10.1007/s11101-014-9369-x
357. Medicine NLO. Diabetes. MedlinePlus. Available from:
346. Putta S, Sastry Yarla N, Kumar Kilari E, et al. Therapeutic https://medlineplus.gov/diabetes.html [Last accessed on
potentials of triterpenes in diabetes and its associated 2023 Feb 07].
complications. Curr Top Med Chem. 2016;16(23):2532-2542.
358. HealthCentral. Type 1 Diabetes: Everything You Need to
doi: 10.2174/1568026616666160414123343 Know. Available from: https://www.endocrineweb.com/
conditions/type-1-diabetes [Last accessed on 2023 Feb 07].
347. Murali R, Karthikeyan A, Saravanan R. Protective effects
of D‐limonene on lipid peroxidation and antioxidant 359. Athipornchai A, Kumpang R, Semsri S. Potential biological
enzymes in streptozotocin‐induced diabetic rats. Basic Clin activities of Clausena essential oils for the treatment of
Pharmacol Toxicol. 2013;112(3):175-181. diabetes. J Oleo Sci. 2021;70(11):1669-1676.
Volume 7 Issue 3 (2024) 29 doi: 10.36922/itps.0332

